Corbus Pharmaceuticals Holdings, INC. (CRBP) — 10-Q Filings

All 10-Q filings from Corbus Pharmaceuticals Holdings, INC.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (5)

Corbus's Net Loss Widens to $10.2M Amid R&D Shifts — Aug 5, 2025 Risk: high
Corbus Pharmaceuticals Holdings, Inc. reported a net loss of $10.2 million for the three months ended June 30, 2025, a significant increase from the $7.8 millio
Corbus Pharma Files 10-Q for Q1 2025 — May 6, 2025 Risk: medium
Corbus Pharmaceuticals Holdings, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including assets and liabil
Corbus Pharmaceuticals Files Q3 2024 10-Q — Nov 7, 2024 Risk: medium
Corbus Pharmaceuticals Holdings, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported on its financial position and business opera
Corbus Pharma Files 10-Q, Details Loan and Warrant Activity — Aug 6, 2024 Risk: medium
Corbus Pharmaceuticals Holdings, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported on its financial condition, including details on
Corbus Pharmaceuticals Holdings, Inc. Files 10-Q for Period Ending March 31, 2024 — May 7, 2024 Risk: low
Corbus Pharmaceuticals Holdings, Inc. (CRBP) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Corbus Pharmaceuticals Holdings, Inc. filed a 10-Q rep

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX